We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 4,194

DOJ's second Opinion Release of 2014: Is DOJ evolving away from the Halliburton opinion standard?

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • November 19 2014

The Department of Justice (“DOJ” or the “Department”) just issued its most recent FCPA Opinion Release, only the second in 2014. The Requestor, a

Valeant fails in its effort to acquire Allergan what is the future of the bidder-activist collaboration model?

  • Fried Frank Harris Shriver & Jacobson LLP
  • -
  • USA
  • -
  • November 19 2014

On Monday, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant

Halliburton’s acquisition of Baker Hughes likely to receive close antitrust scrutiny from Department of Justice

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • November 19 2014

On November 17, 2014, Halliburton Company ("Halliburton") announced plans to acquire Baker Hughes, Inc. ("Baker Hughes") for $34.6 billion

Negotiating your Series A financing

  • Bryan Cave LLP
  • -
  • USA
  • -
  • November 19 2014

Completing your initial equity financing with outside investors is likely to be one of your first experiences in financing your company. Typically

Sources of funding

  • Bryan Cave LLP
  • -
  • USA
  • -
  • November 19 2014

Friends and Family When a company and its founder have exhausted the usual means of generating early financing (that is, maxing out the founder’s

M&A and Corporate Governance Newsletter-Fall 2014

  • Kaye Scholer LLP
  • -
  • USA
  • -
  • November 18 2014

On November 4, 2014, the district court in Allergan, Inc. v. Valeant Pharmaceuticals Int'l, Inc., Case No. SACV 14-1214 (C.D. Cal.) ruled on

Tax Court characterizes technology executive’s merger proceeds as ordinary income

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • November 18 2014

On October 30th, the U.S. Tax Court ruled that a key executive of a technology company acquired by Google for $93 million was required to report a

A Q&A with digital media investors part II: advice for digital media companies

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 18 2014

As noted in Part I: Digital Media Funding Trends, Foley Partner Beth Felder gathered a group of digital media investor experts Don Dodge, Developer

Inside the courts - November 2014

  • Skadden Arps Slate Meagher & Flom LLP
  • -
  • USA
  • -
  • November 17 2014

This issue of Inside the Courts, Skadden’s securities litigation newsletter, includes summaries and associated court opinions of selected cases

Can undue concentration in financial companies threaten market stability? New Federal Reserve merger and acquisition regulation seeks to prevent risk

  • Reed Smith LLP
  • -
  • USA
  • -
  • November 17 2014

The new year will bring new restrictions on banks and certain large financial institutions, as the Federal Reserve Board issued a final rule